Overview
Legal name
METALYNX LTD
Region
London
Registered address
71-75 SHELTON STREET
LONDON
ENGLAND
WC2H 9JQ
Insolvency history
No
Company
Active
LTD
Company profile
Metalynx Ltd
Healthcare AI evaluation and monitoring
Software for independent assessment and monitoring of healthcare AI products. Working with clinical sites to rapidly identify the products that offer greatest clinical benefit for their patients, and with vendors to gather clinical evidence to accelerate sales or monitor for post-market surveillance regulatory reporting.
CRN
12648579
Founded
2020
Age
6
Latest accounts
Financial period: 1 Jul 2023 to 30 Jun 2024
FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
4
Company events
Reference milestones and recent Companies House filing stream events.
6 events
31 Mar
2027
Accounts due
Accounts DueNext accounts due date
27 Dec
2026
Confirmation statement due
Confirmation DueNext confirmation statement due date
13 Dec
2025
Confirmation statement filed
ConfirmationLast confirmation statement made up date
30 Jun
2025
Accounts filed
AccountsLast accounts made up date
18 Nov
2024
Capital Allotment Shares
CapitalSH01 | Transaction MzQ0Mzc3NzI5NGFkaXF6a2N4
Published 18 Nov 2024 09:50
05 Jun
2020
Incorporated
InceptionCompany registered at Companies House
Public funding
3 awards
First funded
2022
Funded years
2022, 2023, 2024
Age at first award
2 years
Projects
2024
Collaborative R&D
Lead participant
Accelerating trustworthy AI in radiology: scalable software for clinical users to independently validate commercial products at local sites
1 Apr 2024 to 31 Mar 2025
Awarded
£378,318
Total cost £540,454
In this collaborative proposal, the Aival Analysis Lab will be used to evaluate commercial radiology AI products on imaging data representative of a broad Scottish population. We will consider two clinical treatment pathways in line with NHS Scotland service and procurement priorities: stroke triage and urgent suspicion of lung cancer triage, assessing at...
2023
Collaborative R&D
Lead participant
Accelerating adoption of trustworthy AI in radiology: scalable software for non-technical clinical users to independently validate commercial products at local sites
1 May 2023 to 31 Jul 2023
Awarded
£47,580
Total cost £47,580
We propose a novel and radical solution that allows healthcare providers and hospitals to rapidly evaluate and test radiology AI products in an independent manner, at a fraction of the resource cost of current evaluation frameworks. An increasing and aging population, with more long-term health conditions, is putting increasing strain on the healthcare sy...
2022
Collaborative R&D
Lead participant
Unlocking the potential of Computer Vision (CV) for SMEs -- Development of an AI platform enabling non-technical users to build advanced CV applications
1 Oct 2022 to 31 Mar 2024
Awarded
£258,907
Total cost £369,867
**Unlocking the potential of Computer Vision for SMEs - Development of an AI platform enabling non-technical users to build advanced CV applications** There is a significant amount of useful information and value locked in visual images, however the high cost of computer vision expertise and the time it takes to analyse and curate the data, means it's cur...
Product types
Collaborative R&D